RN
Ramanjaneya Nagarajagupta Koppal
About Ramanjaneya Nagarajagupta Koppal
Data last updated:
Ramanjaneya Nagarajagupta Koppal is a Director at Govaxo Pharma Sales Private Limited (since 2018), Director at Ryzomed Biopeutics Private Limited (since 2025) and Designated Partner at Rakesh Indu Medicare Llp (since 2024). The companies operate in Pharma. The largest current company by reported revenue is Govaxo Pharma Sales Private Limited at ₹11.98 Cr (FY 2024).
Current companies
| Company | Designation | Appointment | Founded | Revenue | Status |
|---|---|---|---|---|---|
 Govaxo Pharma Sales Private Limited U74990KA2018PTC116122 | Director | 07 Sep 2018 | 2018 | ₹11.98 Cr (FY 2024) | Active |
| Ryzomed Biopeutics Private Limited U46900KA2025PTC199149 | Director | 04 Mar 2025 | 2025 | Active | |
| Rakesh Indu Medicare Llp ACJ-1581 | Designated Partner | 28 Aug 2024 | 2024 | Active |
Board colleagues of Ramanjaneya Nagarajagupta Koppal
| Name | DIN | Company | Designation |
|---|---|---|---|
| Hareesh Jayaseelareddy | 08218065 | Govaxo Pharma Sales Private Limited | Director |
| Kittur Ramaiah Krishnaswamy | 08223070 | Govaxo Pharma Sales Private Limited | Director |
| Koppal Ramanjaneya Rakesh | 08226386 | Govaxo Pharma Sales Private Limited , Ryzomed Biopeutics Private Limited | Director |
| Neelanahalli Shivannagowda Indresh | 07522101 | Rakesh Indu Medicare Llp | Designated Partner |
Directorship timeline
Open interactive timeline →Shareholding and investment profile for Ramanjaneya Nagarajagupta Koppal
Company-level share counts, filed values, and quarterly changes require authenticated premium access.
- Company-level holdings
- Filed share counts
- Reported values
- Quarterly changes
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Ramanjaneya Nagarajagupta Koppal
Ramanjaneya Nagarajagupta Koppal currently holds 3 directorships: Govaxo Pharma Sales Private Limited (Director, since 07 Sep 2018, revenue ₹11.98 Cr (FY 2024)); Ryzomed Biopeutics Private Limited (Director, since 04 Mar 2025); Rakesh Indu Medicare Llp (Designated Partner, since 28 Aug 2024).
Ramanjaneya Nagarajagupta Koppal was first appointed on 07 Sep 2018 as Director at Govaxo Pharma Sales Private Limited. The most recent appointment on record is 04 Mar 2025 at Ryzomed Biopeutics Private Limited.
The current boards of Ramanjaneya Nagarajagupta Koppal's companies include Hareesh Jayaseelareddy (Govaxo Pharma Sales Private Limited), Kittur Ramaiah Krishnaswamy (Govaxo Pharma Sales Private Limited), Koppal Ramanjaneya Rakesh (Govaxo Pharma Sales Private Limited), Neelanahalli Shivannagowda Indresh (Rakesh Indu Medicare Llp).